IMI Primers and Probe

IMI Primers and Probe

Carbapenem based antibiotics have become the first line choice in the treatment of ESBL infections. Of significant global concern therefor is the emergence of carbapenem resistant (CPO) bacteria in healthcare settings, as standard treatments may be rendered ineffective.

CPO Targets